Skip to content

Clinical Study on Safety and Effectiveness of Iliac Vein Stent System in Treating Iliac Vein Stenosis or Occlusion.

Clinical Study on Safety and Effectiveness of Iliac Vein Stent System in Treating Iliac Vein Stenosis or Occlusion.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034349
Enrollment
Unknown
Registered
2020-07-03
Start date
2018-09-30
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb or/and pelvic venous reflux caused by Iliac vein stenosis or occlusion

Interventions

Experimental group:Vein Stent System
Control group:Zilver Vena

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. iliac vein stenosis >=50% or occlusion (DSAorCTV); 3. CEAP clinical grade C >=3; 4. patients voluntarily sign informed consent and complete follow-up.

Exclusion criteria

Exclusion criteria: 1. Stenting parts always underwent interventional surgery or for previous surgery patients with stent placement; 2. Iliac vein stricture was caused by pelvic tumor compression, caused by tumor after radiotherapy, thrombosis syndrome (PTS), half a year internal cause diagnosis of acute lower extremity deep vein thrombosis (DVT) catheter thrombolysis or should left iliac vein stricture postoperatively; 3. subjects are allergic to contrast agents and anesthetics; 4. Serious patients had coagulant function abnormality; 5. Patients with severe liver and kidney dysfunction; 6. By reason of malignant tumor, life expectancy of patients less than 12 months; 7. Iliac vein of iliac vein stent system shall not apply to the specifications; 8. To the product material (nickel titanium and tantalum) patients with a history of allergies; 9. 12 months of men and women have fertility planning; 10. The researchers determine patient adherence is poor, can't do research according to the requirements.

Design outcomes

Primary

MeasureTime frame
Patency rate of vein 12 months after operation;

Countries

China

Contacts

Public ContactXiaoqiang Li

Intervention Department, Nanjing Drum Tower Hospital

flytsg@126.com+86 18906206898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026